Zobrazeno 1 - 10
of 28
pro vyhledávání: '"F I Preffer"'
Publikováno v:
The Journal of Immunology. 144:4604-4612
These studies test whether allograft rejection can be blocked by interference with leukocyte adhesion, using a murine IgG2a mAb (R6.5) reactive with monkey ICAM-1 (CD54). In 16 Cynomolgus renal allograft recipients, R6.5 was administered prophylactic
Publikováno v:
Anticancer research. 22(4)
Multidrug resistance is a significant barrier to the development of successful cancer treatment. To identify genetic alterations that are directly involved in paclitaxel resistance, a functional cloning strategy was developed.Using mRNA from paclitax
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 11
In view of the successful use of serotherapy in many B-cell malignancies, we and others have sought to identify tumor selective antigens for the serotherapy of plasma cell dyscrasias (PCD) including multiple myeloma (MM), and Waldenstrom's macroglobu
Publikováno v:
American journal of respiratory and critical care medicine. 161(2 Pt 1)
Pulmonary immunity reflects a balance between proinflammatory and immunosuppressive factors in the lung. To determine the immune activities of exudate macrophages in the pulmonary immune response, Lewis rats were injected intratracheally with heat-ki
Autor:
P T, Masiakos, D T, MacLaughlin, S, Maheswaran, J, Teixeira, A F, Fuller, P C, Shah, D J, Kehas, M K, Kenneally, D M, Dombkowski, T U, Ha, F I, Preffer, P K, Donahoe
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(11)
Six human ovarian cancer cell lines and samples of ascites cells isolated from 27 patients with stage III or IV ovarian papillary serous cystadenocarcinoma were studied individually to test whether recombinant human Mullerian inhibiting substance (rh
Autor:
S P, Treon, Y, Shima, F I, Preffer, D S, Doss, L, Ellman, R L, Schlossman, M L, Grossbard, A R, Belch, L M, Pilarski, K C, Anderson
Publikováno v:
Seminars in oncology. 26(5 Suppl 14)
The use of serotherapy to treat patients with plasma cell dyscrasias (PCDs) has been sought by us and others. Candidate antigens that have been targeted or proposed for targeting in PCDs include the immunoglobulin idiotype, CD19, CD38, CD54, CD126, H
Autor:
G J, Mourad, F I, Preffer, S L, Wee, J A, Powelson, T, Kawai, F L, Delmonico, R W, Knowles, A B, Cosimi, R B, Colvin
Publikováno v:
Transplantation. 65(5)
Optimizing therapeutic monoclonal antibody (mAb) depends on the incorporation of the necessary effector functions and the development of hypoantigenic "humanized" antibodies by genetic engineering, which then need to be tested in appropriate preclini
Publikováno v:
Cytometry. 28(1)
Previous reports have shown, using fluorescent probes conjugated to the organism, that Mycoplasma fermentans fuses with about 12% of peripheral blood lymphocytes. However, no lymphocyte subset was specified. To elucidate the specific subset of lympho
Autor:
S M, Meehan, R T, McCluskey, M, Pascual, F I, Preffer, P, Anderson, S F, Schlossman, R B, Colvin
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 76(5)
In the present study, we analyzed human renal allografts using immunohistochemical techniques to determine the site, identity, and frequency of (a) cytotoxic and apoptotic cells, as identified by staining for GMP-17 (TIA-1), a component of cytotoxic
Publikováno v:
Advances in experimental medicine and biology. 417